Unlike cancer cells, there is a lack of direct evidence supporting the connection between the anti-atherogenic effect of luteolin and apoptosis signaling pathways, such as Bcl-2, Bax, Caspase and its role in VSMCs. The gene discussed is BCL2; the disease is cancer.